Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 5, 2022

Primary Completion Date

January 3, 2023

Study Completion Date

January 3, 2023

Conditions
Adverse Effect
Interventions
DRUG

Phenylephrine

An initial prophylactic bolus dose of phenylephrine (37.5μg) simultaneous with spinal anesthesia. If the patient did not respond adequately to the current dose (SBP decreased to \< 80% of baseline), the dose was considered to have failed and the subsequent dose for the following patient was increased to the next higher dose level. The dose administered to subsequent patients varied by increments or decrements of 12.5 μg according to the responses of previous patients according to the up-down sequential allocation.

DRUG

Norepinephrine

An initial prophylactic bolus dose of norepinephrine (3μg) simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 1 μg according to the responses of previous patients according to the up-down sequential allocation.

Trial Locations (1)

Unknown

General Hospital of Ningxia Medical University, Yinchuan

All Listed Sponsors
lead

General Hospital of Ningxia Medical University

OTHER